Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves
| dc.contributor.author | Carnicelli, Anthony P. | |
| dc.contributor.author | De Caterina, Raffaele | |
| dc.contributor.author | Halperin, Jonathan L. | |
| dc.contributor.author | Renda, Giulia | |
| dc.contributor.author | Ruff, Christian T. | |
| dc.contributor.author | Trevisan, Marco | |
| dc.contributor.author | Nordio, Francesco | |
| dc.date.accessioned | 2024-02-23T14:26:43Z | |
| dc.date.available | 2024-02-23T14:26:43Z | |
| dc.date.issued | 2017 | |
| dc.department | NEÜ | en_US |
| dc.description.abstract | [Abstract Not Availabe] | en_US |
| dc.description.sponsorship | Daiichi Sankyo | en_US |
| dc.description.sponsorship | The ENGAGE AF-TIMI 48 trial was supported by a research grant from Daiichi Sankyo to the Brigham and Women's Hospital. All analyses were conducted independently by the Thrombolysis In Myocardial Infarction (TIMI) Study Group, and all authors had full access to the data. The authors are fully responsible for the study design, data collection, analysis and interpretation of the data, and the writing of the manuscript. The sponsor played no role in the decision to submit the manuscript for publication. | en_US |
| dc.identifier.doi | 10.1161/CIRCULATIONAHA.116.026714 | |
| dc.identifier.endpage | 1275 | en_US |
| dc.identifier.issn | 0009-7322 | |
| dc.identifier.issn | 1524-4539 | |
| dc.identifier.issue | 13 | en_US |
| dc.identifier.pmid | 28209729 | en_US |
| dc.identifier.scopusquality | Q1 | en_US |
| dc.identifier.startpage | 1273 | en_US |
| dc.identifier.uri | https://doi.org/10.1161/CIRCULATIONAHA.116.026714 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12452/14311 | |
| dc.identifier.volume | 135 | en_US |
| dc.identifier.wos | WOS:000397387200020 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.indekslendigikaynak | PubMed | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Lippincott Williams & Wilkins | en_US |
| dc.relation.ispartof | Circulation | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.subject | Anticoagulation | en_US |
| dc.subject | Atrial Fibrillation | en_US |
| dc.subject | Bioprosthetic Valve | en_US |
| dc.subject | Edoxaban | en_US |
| dc.subject | Warfarin | en_US |
| dc.title | Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves | en_US |
| dc.type | Letter | en_US |












